Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
Acrux Ltd
(2019
sales of 5.29 million Australian Dollars [US$3.63 million]
of which 12%
was Other),
Pharmaust Limited
(4.36 million Australian Dollars [US$3.00 million]
), and
AFT Pharmaceuticals Ltd
which is
based in New Zealand
(85.13 million New Zealand Dollars [US$53.91 million]
of which 59%
was Australia).
Sales Analysis.
Probiotec Limited reported sales of A$79.09 million (US$54.28 million)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 4.4%
versus 2018, when the company's sales were A$75.72 million.